Flashcards Studio

An agency of the Philippine government, the Department of Health (Food and Drug Administration, FDA) issues three issuances:
1) A substantive rule titled “Regulation on Mandatory Certification and Labeling of Over‑the‑Counter Drugs” requiring all OTC drugs sold in the Philippines to display a DOH certification seal and comply with specified labeling standards; the rule is published in the Official Gazette and circulated to industry stakeholders with penalties for noncompliance.
2) An interpretative rule issued as a guidance letter interpreting the term “drug” in the DOH regulatory statute to include certain phytopharmaceuticals that are regulated under DOH; the guidance does not create new duties beyond what the statute imposes.
3) A procedural rule in the form of a memorandum directing importers to file electronic copies of batch-release certificates with the FDA online portal within 7 days of batch release; the rule governs the process by which the agency collects information from applicants and importers.
(a) For each issuance, identify what kind of administrative rule it is (substantive/quasi-legislative, interpretative, or procedural) and justify your classification.
(b) State, with brief explanation, whether each rule is binding on private persons and whether publication/notice is required for validity, including any limitation on enforcement.
(c) Apply the governing principles to these facts: are each issuance valid and enforceable given the Philippine doctrine on quasi-legislative rule-making? If any is vulnerable, explain the basis (e.g., ultra vires, lack of publication, or overstep of authority).